Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activities-Reference-Cited by-同舟云学术

Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activities

Published:2002-10-30 Issue:7 Volume:16 Page:632-638
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytother. Res.

Author:

Zuber Roman,Modrianský Martin,Dvořák Zdeněk,Rohovský Petr,Ulrichová Jitka,Šimánek Vilím,Anzenbacher Pavel

Funder

Ministry of Health of the Czech Republic

Ministry of Education, Youth and Sports

Grant Agency of the Czech Republic

Publisher

Wiley

Subject

Pharmacology

Reference19 articles.

1. Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds;Baer-Dubowska;Xenobiotica,1998

2. Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes;Beckmann-Knopp;Pharmacol Toxicol,2000

3. Effect of methanol, ethanol, dimethylsulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450;Busby;Drug Metabol Dispos,1999

4. Methods in Molecular Biology;Chang,1998

5. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes;Chauret;Drug Metabol Dispos,1998

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress in Natural Products against Liver Fibrosis;The Natural Products Journal;2024-06-04

2. Silybin A fromSilybum marianumreprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids;2024-04-11

3. Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases;Journal of Medicinal Chemistry;2024-02-13

4. Treatment of denture stomatitis using iron nanoparticles green-synthesized by Silybum marianum extract;Open Chemistry;2023-01-01

5. A case of hepatitis induced by herbal medicine in non-small cell lung cancer patient treated by a combination of immunotherapy and chemotherapy;Journal of Oncology Pharmacy Practice;2022-04-28